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Abstract
Tissue engineering (TE) is an emerging field for the regeneration of damaged tissues. The
combination of hydrogels with stem cells and growth factors (GFs) has become a promising
approach to promote cartilage regeneration. In this study, carrageenan-based hydrogels were
used to encapsulate both cells and transforming growth factor-b1 (TGF-b1). The ATDC5 cell
line was encapsulated to determine the cytotoxicity and the influence of polymer concentration
on cell viability and proliferation. Human adipose-derived stem cells (hASCs) were encapsulated
with TGF-b1 in the hydrogel networks to enhance the chondrogenic differentiation of hASCs.
Specific cartilage extracellular matrix molecules expression by hASCs were observed after
14 days of cultures of the constructs under different conditions. The k-carrageenan was found
to be a suitable biomaterial for cell and GF encapsulation. The incorporation of TGF-b1 within the
carrageenan-based hydrogel enhanced the cartilage differentiation of hASCs. These findings
indicate that this new system for cartilage TE is very promising for injectable
thermoresponsive formulation applications.
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Introduction
Tissue engineering (TE) is an emerging multidisciplinary ﬁeld that may revolutionize the ways
to improve the health and quality of life worldwide by restoring, maintaining, or enhancing
tissue and organ functions.1,2 Cartilage is an avascular, aneural, and alymphatic tissue
composed of a unique type of cell, chondrocyte, which is embedded within a dense
extracellular matrix (ECM).3 The matrix is composed of collagens and proteoglycans, which
provide the architectural structure and biochemical strength to the tissue.4 Joint diseases,
osteoarthritis, direct or indirect trauma from sports injuries, and premature or
osteochondral cartilage degeneration are targets among cartilage TE repair.5–7
A typical cartilage TE approach combines cells, biomaterials, and signaling factors.4,8–11
Cartilage regeneration using autologous chondrocytes has been indicated.12,13 However,
posterior in vitro cultures for cell expansion are required, which is typically associated
with cell de-diﬀerentiation, leading to the downregulation of cartilage-speciﬁc genes.14
Alternative cell sources, namely adult mesenchymal stem cells (MSCs), including adipose-
derived stem cells (ASCs), have been reported.15,16
Adipose tissue is easy to access in individuals, and contains a large proportion of MSCs.17
The easy access to ASCs by liposaspiration is one of the greatest advantages of this stem cell
source. Furthermore, the ASCs can undergo diﬀerentiation into diﬀerent lineages, including
the chondrogenic cells.18 Under speciﬁc conditions, which include culturing ASCs in an
environment supplemented with transforming growth factor-b (TGF-b), dexamethasone,
and ascorbate, stem cells undergo chondrogenic diﬀerentiation.18–22
TGF-b1 is known to be responsible for initial cell–cell interactions and for the stimulation
of cells to grow and diﬀerentiate.23–26 TGF-b is responsible for the control of chondrocyte
proliferation and diﬀerentiation. Furthermore, it is able to induce chondrogenic
diﬀerentiation of MSCs in vitro.23–25,27 TGF-b1 is also important for the production of
proteoglycans and other components of cartilage matrix.27,28 Studies have been focused
on the delivery of this growth factor (GF) in hydrogels and evaluated their inﬂuence in
neocartilage tissue development.28–30
An important parameter in cartilage TE is the choice of the appropriate three-
dimensional (3D) support. Biocompatibility, porosity, pore size, surface and mechanical
properties, and biodegradability are essential parameters that should be speciﬁcally
designed in order to achieve successful tissue regeneration.31 Hydrogels are particularly
suitable for cartilage TE as they resemble the 3D aqueous-rich environment of that
tissue.32,33 Hydrogels with appropriate mechanical properties, capable of entrapping cells
and allowing the diﬀusion of nutrients through the mesh, can be used as a construct for
cartilage TE. Moreover, stimuli-responsive (pH and temperature) hydrogels represent a
promising approach as they can be injected by a minimal invasive procedure which is
advantageous over other more complex treatments involving open body surgeries.32,34
Although the use of synthetic polymers to design hydrogels may seem promising, the
choice of natural biomaterials assumes greater relevance in the objective of mimicking the
nature due to their high biocompatibility.35 Polysaccharides are the most versatile natural
polymers due to the wide range of chemical, physical, and functional properties they convene
in living organisms.36–39
Carrageenan, a sulfated polysaccharide that is extracted from red marine algae, is gaining
interest for biomedical applications due to its facile gellation. It is comprised of
repeating disaccharide units of 4-linked b-D-galactopyranose (G-unit) and 4-linked
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a-D-galactopyranose (D-unit) or 4-linked 3,6-anhydrogalactose (DA-unit), with a variable
portion of sulfate groups.39–41 According to the position and number of sulfate groups in the
1,3- and 1,4-linked galactose residues, carrageenans are divided into three families: k, i, and
, corresponding to one, two, and three sulphate groups per disaccharide.40 In aqueous
solutions and in the presence of cations, both k- and i-carrageenans easily form, on
cooling, thermoreversible gels.
The objective of this study was to design of a new carrageenan-based thermoreversible
hydrogel for use in cartilage TE applications. Further, the eﬀect of the TGF-b1 in the
hydrogel network was studied with respect to the proliferation and chondrogenic
diﬀerentiation of encapsulated human (hASCs).
Materials and methods
Hydrogel preparation
k-Carrageenan hydrogels were formed by ionic crosslinking monovalent cations, such as Kþ.
k-Carrageenan (Sigma–Aldrich) solutions with 2% and 2.5% (w/v) in distilled water. The
dispersion was heated in a water bath at 60C with stirring until a homogeneous solution
formed. The solutions were sterilized in an autoclave (121C for 30min). The polymer
solution was then poured into a Petri dish and allowed to gel. To croslinked the structure,
5% (w/v) potassium chloride (KCl) solution in phosphate-buﬀered saline (PBS) was added
in a volume ratio of 4/1 (KCl solution/polymer solution), and allowed to react for 30min.
The hydrogel obtained was washed several times with PBS, and discs of ~5  2mm2 were
produced with a punch.
CryoSEM
The internal morphology of the hydrogels was evaluated by CryoSEM. Samples were cooled
rapidly down to 210C, followed by surface sublimation and coated with gold–palladium
to avoid deposition of electron ﬂux. Images were obtained in a microscope (SEM; JEOL
JSM 6301F/Oxford INCA Energy 350/Gatan Alto 2500 from CEMUP laboratories (REEQ/
1062/CTM/2005 e REDE/1512/RME/2005)).
Cell culturing and expansion
Two diﬀerent types of cells, mouse embryonal carcinoma-derived clonal cell line ATDC5
(ECACC, UK) and human adipose-derived stem cells (hASCs), were used. Over the course
of the cell culture period, samples were monitored with an inverted microscope (Axiovert 40
PG-HITEC, Zeiss).
Culture of ATDC5 cells
ATDC5 cells were defrosted at passage 8 and cultured for 2weeks to obtain a suﬃcient cell
number for the experiment. Cells were cultured in Dulbecco’s modiﬁed eagle medium
nutrient mixture F-12 (DMEM F-12) supplemented with 10% fetal bovine serum (FBS,
Invitrogen Corporation, USA), sodium bicarbonate (NaHCO3), and L-glutamine at 37
C,
5% CO2 incubator. Medium was changed every 2 days.
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Isolation and culture of hASCs
Human subcutaneous adipose tissue samples were obtained from lipoaspiration procedures
performed on females, 35–50 years of age, under a protocol previously established with the
Department of Plastic Surgery of Hospital da Prelada in Porto, Portugal. All the donations
were provided with informed consent from the patients. All samples were processed within
24 h after the lipoaspiration procedure. Human ASCs were enzymatically isolated from
subcutaneous adipose tissue as previously described.19,20,42,43 The lipoaspirate samples
were ﬁrst washed with a solution of PBS and 10% Antibiotic/Antimycotic (Gibco, UK).
Liposuction tissue was digested with 0.2% collagenase Type II solution (Sigma) for 11/2 h at
37C with intermittent shaking. The digested tissue was ﬁltered using a 100-mm ﬁlter mesh.
The ﬂoating adipocytes were separated from the precipitation stromal fraction by
centrifugation at 1250 rpm for 10min. The cell pellet was suspended in lysis buﬀer for
10min to disrupt the erythrocytes. After a centrifugation at 800 rpm for 10min, cells were
again suspended and placed in culture ﬂasks with minimum essential a-medium (Invitrogen
Corporation) supplemented with sodium bicarbonate, antibiotic/antimicotic (with 10,000
units of penicillin, 10mg of streptomycin, and 25 mg of amphotericin B per mL (Sigma),
and 10% of FBS. The cells were cultured until suﬃcient number of cells were obtained at
37C in a 5%CO2 incubator and changing the medium every 2 days.
Cell and GF encapsulation
To study the ability of the carrageenan hydrogels for cell encapsulation, ATDC5 cells were
used as models to evaluate the eﬃciency of the system. Three diﬀerent formulations were
prepared: I – carrageenan-only hydrogels (2% and 2.5% (w/v)), II – carrageenan hydrogels
(2% and 2.5% (w/v) encapsulating ATDC5 cells, and III – carrageenan hydrogels (2% and
2.5% (w/v), encapsulating ATDC5 cells and TGF-b1. The encapsulation of cells was
performed by quick addition of the cell suspension in PBS to the polymer solution at a
ratio of 1/20 (v/v) at 40C. The solution was mixed every few seconds to disperse the cells
and then 5mL of the mixture poured into each Petri dish. GF (100 mg/mL) was dissolved in
PBS and mixed with the carrageenan/cell suspension prior to the sol–gel transition to include
TGF-b1 in the hydrogel network. ATDC5–carrageenan constructs were prepared with a cell
density of 5  106/mL of ﬁnal solution, and cultured for 1week.
The formulation chosen for the diﬀerentiation study was the 2% (w/v) k-carrageenan
hydrogels crosslinked in 5% (w/v) KCl for 30min. The ASCs were incorporated into the
hydrogels following the procedure described above for the ATDC5 cell line. Human ASCs
were encapsulated in the carrageenan hydrogels with a ﬁnal density of 2/mL of ﬁnal solution
and cultured for 14 days. Three diﬀerent formulations A, B, and C were prepared as follows:
(A) k-carrageenan hydrogels encapsulating hASCs and TGF-b1 cultured in chondrogenic
medium; (B) carrageenan hydrogels encapsulating hASCs cultured in chondrogenic medium;
and (C) k-carrageenan hydrogels encapsulating hASCs and TGF-b1 cultured in basal
medium. The ﬁnal TGF-b1 amount in each disc was 10 ng.
Culture conditions
ATDC5 constructs were cultured in vitro in 48-well plates with 500 mL of culture medium per
sample of DMEM-F12 supplemented with 10% FBS, NaHCO3, and L-glutamine. Medium
was changed every 2 days, and speciﬁc discs were collected for analysis at days 1 and 7 for
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3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay (n¼ 3), deoxyribonucleic acid (DNA) assay (n¼ 3), histology, and
immunohistochemistry (n¼ 3).
Human ASCs–carrageenan constructs were cultured under two diﬀerent conditions (all
reagents were obtained from Sigma, USA). Formulations A and B were cultured in
chondrogenic medium low-glucose DMEM supplemented with sodium bicarbonate,
antibiotic/antimicotic, ITS(+) (insulin–transferrin–selenium), ascorbic acid, sodium
pyruvate, L-proline, dexamethasone, and growth factor TGF-b1 (Sigma–Aldrich,
Portugal). Discs from formulation C were cultured in DMEM supplemented with
sodium bicarbonate, antibiotic/antimicotic (with 10,000 units of penicillin, 10mg of
streptomycin, and 25 mg of amphotericin B per mL), and 10% of FBS. The medium was
changed every 2 days (500 mL), speciﬁc discs were collected for analysis at days 1, 7, and 14
for the MTS assay (n¼ 3), DNA assay (n¼ 3), and histology and immunohistochemistry
(n¼ 3).
Live/dead assay. Viability live/dead analysis was performed with Calcein AM/Propidium
iodide (PI) solution. Calcein AM (Invitrogen Corporation, USA) was diluted in serum-free
basal medium, and PI working solution (Invitrogen Corporation, USA) prepared with
RNAse A (USB corporation, USA) in PBS. Samples were collected after the
encapsulation process, and 100 mL of each working solution was added to samples and
incubated for 10min at 37C and protected from light. The cells were assayed with a
ﬂuorescence microscope (Stemi 1000 PG-HITEC Zeiss) with green and red ﬁlters.
Cell viability (MTS assay). The viability of the encapsulated cells within the hydrogel was
evaluated using the MTS assay at speciﬁc times. At each time point, the culture medium
from the samples was removed and replaced with 0.5mL fresh serum-free medium
supplemented with MTS stock solution in 5:1 (v/v) ratio. After incubating at 37C, in a
5% CO2 incubator, the medium was collected and analyzed with a Microplate Reader
(Synergie HT Izasa) at 490 nm.
DNA quantification. DNA content in the scaﬀold was determined using the ﬂuorescent
picoGreen dsDNA (ds, double stranded) quantiﬁcation assay (Invitrogen Corporation,
USA). Samples collected at each time point were washed in PBS, 1mL of ultra-pure
water was added, and samples stored at 80C until testing. Before testing, samples
were sonicated for disrupting cell membranes in a water bath for 15min. The samples
were then analyzed with a microplate reader in a ﬂuorescent mode at 485–528 nm
(Synergie HT Izasa).
Histological analysis. The samples at each time point were washed in PBS and ﬁxed with
10% formalin for about 1 h at 4C. After ﬁxation, the samples were rinsed in PBS and
dehydrated by serial immersion in a series of increasing concentration of ethanol solutions
(70%, 90%, 95%, and 100%) and xylene performed with a spin tissue processor (Microm
ST120, INOPAT). Specimens were then embedded in paraﬃn and cut into 3-mm sections
using a Microtome (Microm HM355S, INOPAT). Prior to staining, sections were dewaxed
at 70C for 15min and rehydrated in a series of ethanol/water solutions. The toluidine blue
and Alcian blue-stained samples were analyzed with a stereo microscope (Stemi 1000
PG-HITEC Zeiss) and the images collected in digital cameras.
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Immunohistochemical analysis. Samples pre-ﬁxed with 10% formalin for about 1 h at 4C
were cut into 3-mm section, and slides were deparaﬃnized and dehydrated in an automatic
stainer (Microm HMS740, INOPAT). Slides were then rinsed in a PBS buﬀer for 5min, and
then immersed for 30min into a hydrogen peroxide solution to inactivate endogenous
peroxidase. The slides were washed again with PBS for 5min and incubated with 5%
powdered milk for 10min at room temperature to avoid unspeciﬁc reactions. The ﬁrst
antibody used was Anti-type II collagen UNLB (goat) (SantaCruz, USA) for 1 h at room
temperature. After the slides were rinsed in PBS for 5min, the secondary antibody,
polyclonal swine anti-goat, mouse, rabbit imunoglobu-biotinylated (Dako, Denmark), was
incubated for 30min at room temperature. After one more washing, the samples were
incubated for 30min with Vectastain R.T.U. Elite ABC Reagent. The ﬁnal substrate
reagent was added at room temperature for 10min to develop staining, slides washed in
tap water for 5min and mounted. Positive control consisted of sections of HAC tissue, and
negative controls consisted of sections incubated with PBS instead of the primary antibody.
Statistical analysis
All the experiments were performed with at least three replicates. Results are expressed as the
mean  SD. Diﬀerences between the experimental results were analyzed according to a
Student’s t-test, with the limit for statistical signiﬁcance being deﬁned as p< 0.01.
Results
Diﬀerent carrageenan hydrogels were successfully prepared based on two diﬀerent polymer
concentrations, 2% and 2.5% (w/v) in distilled water. CryoSEM of the internal morphology
of the hydrogels is shown in Figure 1. The samples prepared with 2.5% (w/v) polymer had
denser networks (Figure 1(b)), compared to 2% carrageenan hydrogels, which had a lesser
Figure 1. CryoSEM images of the surface fracture from carrageenan hydrogels prepared with different
polymer concentrations: (a) 2% (w/v) k-carrageenan hydrogel crosslinked with 5% (w/v) KCl for 30min and
(b) 2.5% (w/v) k-carrageenan hydrogel crosslinked with 5% (w/v) KCl for 30min. Formulation B presents a
general denser crosslinked morphology.
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crosslinked morphology (Figure 1(a)); thus, the water-uptake capability was greater as
conﬁrmed by water uptake measurements.
Viability and proliferation of ATDC5 cells
To assess the carrageenan hydrogels as a cell encapsulation system, the chondrocyte line
ATDC5 was used. Cell viability and proliferation were evaluated by the polymer
concentration (2% and 2.5% (w/v), crosslinking time (30 and 60min), and TGF-b1
incorporation (0 and 100 ng/mL) within the hydrogel. The encapsulation process was
achieved in all formulations and the hydrogels remained stable during the 7-day culture
period.
Increase in polymer concentration and crosslinking degree did not show any negative
eﬀects on the cell viability immediately after the encapsulation step, proven by the live/dead
assay (Figure 2). Moreover, the incorporation of TGF-b1 also did not aﬀect the ratio of live/
dead cells as all the hydrogels showed uniform distributions of viable cells after the
encapsulation process (Figure 2), and similar results were obtained for the diﬀerent
formulations. At higher magniﬁcation (Figure 2(d)), the spherical cellular morphology
typical from an encapsulation in a hydrogel network was clearly observed.
The cell viability and proliferation were followed for 1week of culture. At days 1 and 7,
constructs (n¼ 3) of each formulation were collected for MTS and DNA analyses. The
encapsulated cells were viable for 1week inside the gel. The cells maintained their viability
Figure 2. Live/dead assay, at day 0, for ATDC5 encapsulated in k-carrageenan hydrogels with different
polymer concentrations. Cells entrapped in the hydrogels display spherical morphology in all formulations.
Figures (a) and (b) refer to 2% (w/v) k-carrageenan, while (c) and (d) show cell viability for 2.5% (w/v)
polymer. TGF-b1 was included in (b) and (d). Scale bar represents 100 mm.
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for 1week, without a signiﬁcant decrease, in the hydrogels with 2% (w/v) k-carrageenan.
However, in the 2.5% (w/v) carrageenan hydrogels, the viability decreased signiﬁcantly with
time. It was noted that in most of the constructs with the presence of GF, the cell viability
levels are signiﬁcantly higher than in those without TGF-b1 (p< 0.01) (Figure 3). The
presence of TGF-b1 in the hydrogel network seems to stimulate the proliferation of
ATDC5 cells.
Viability and proliferation of hASCs
At day 0, when hASCs were encapsulated, the live/dead assay conﬁrmed the entrapment of
viable cells into the hydrogels (Figure 4), as the three tested formulations had higher ratio of
green/red cells. The images are representative of the whole 3D cell distribution. In all three
formulations, the cells were distributed homogeneously within the hydrogels with no dead
cells and no signiﬁcant diﬀerences between the three formulations.
The viability of the cells inside the hydrogel was assessed by the MTS assay from 1 to
14 days of culture (Figure 5). The human ASCs cultured in chondrogenic medium had
signiﬁcant higher viability at day 1 compared to constructs cultured in DMEM basal
media. After the ﬁrst day of culture, constructs entrapping TGF-b1 and cultured in
chondrogenic medium had signiﬁcant higher cell viability than the two other
Figure 3. Evaluation of viability (a and b) and proliferation (c and d) of ATDC5 cells encapsulated
in k-carrageenan gels. The symbol * shows significant difference of samples where TGF-b1 is included
comparing for the ones where the GF is absent; the symbol (#) shows difference of samples collected in day
7 from the ones collected in day 1 (p< 0.01).
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formulations. These culture conditions provided higher viability at day 7, but after 2weeks,
all three formulations were similar with no signiﬁcant diﬀerences. The presence of TGF-b1 in
the carrageenan hydrogel enhanced the hASCs viability throughout the culture period
compared to cell-encapsulated hydrogels.
The constructs collected at the ﬁrst day had higher numbers of cells compared to the other
time points of culture. Both samples cultured in chondrogenic medium showed similar
behavior, with a signiﬁcant decrease in cells after 7 days followed by an increase past
14 days. With constructs cultured in DMEM, decrease was observed at each time point.
The hydrogel entrapping both hASCs and TGF-b1 displayed a better proliferation results,
while the formulation cultured in basal media was a more hostile environment for hASC
culture.
Histology and immunohistochemistry
The organization and distribution of hASCs inside the hydrogel, as well as the
accumulation of cartilage-speciﬁc macromolecules was examined by histological and
Figure 4. Viability of hASCs encapsulated in the k-carrageenan hydrogels. Dead cells are presented with
red fluorescence, while green one is indicative of live cells (first two columns, respectively). In third column,
it is possible to observe the ratio between live and dead cells homogenously distributed in the hydrogel.
There are no visible differences in hydrogels with TGF-b1 entrapping (formulations A and C) relating to its
absence (formulation B). Scale bar represents 200 mm.
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immunohistochemical methods. Histological stainings revealed that the cells adopted a
rounded morphology and were well distributed inside the hydrogel. Samples collected
after 14 days in culture showed a signs of sulfated glycosaminoglycans deposition on the
pericellular regions and nearby (Figure 6).44 Constructs cultured in chondrogenic medium
showed a strong presence of cartilage-speciﬁc molecules and the cells that were encapsulated
together with TGF-b1 appear inside a well-deﬁned vacuole. Alcian staining proved the
existence of proteoglycans in the constructs, more evidenced in formulation A. Cells
appear surrounded by a blue ring correspondent to glycan molecules.
Immunohistochemical labeling against collagen type II showed the formation of a matrix
composed of the two types of collagen studied. A strong evidence of collagen type II was
seen in constructs from formulation A in the pericellular matrix of hASCs (Figure 7).
Discussion
The ability of k-carrageenan hydrogels to support the chondrogenic diﬀerentiation of hASCs
was assessed. Stem cells were eﬃciently isolated from adipose tissue by the previously
mentioned procedure.42,45 To emulate chondrogenesis in vivo, high cell density is required
in a 3-D environment that favors cell condensation and cell–cell interactions, analogous to
that which occurs in the formation of native cartilage.22,46
The encapsulation of hASCs inside the hydrogels was successful as only a insigniﬁcant
number of dead cells were observed with live/dead assay. This fact indicated that the cells did
not suﬀer a pronounced thermal shock in contact with the heated carrageenan solution. In
both culture conditions (chondrogenic and basal media), the DNA content decreased with
time. This ﬁnding is consistent with previous studies of hASCs grown within gel matrices,
and it may be due to a combination of cell death or migration from the matrix.19,27,47
Diﬀerences observed in cell viability (Figure 5), suggested a higher encapsulation success
Figure 5. Evaluation of viability and proliferation of hASCs in k-carrageenan hydrogels cultured for
2weeks. The symbol (*) represents significant differences between the formulations related to the previous
time point; (#) the significant differences related to the first day. The effects of TGF-b1 inclusion and the
culture medium were also assessed and (£) represents significant differences related to formulation A, while
(§) the significant differences to formulation B.
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Figure 6. Histological images of hASCs cultured in k-carrageenan hydrogels for 14 days. Toluidine staining
showed the spherical shape of the cells, surrounded by a vacuole. Some extracellular matrix is clearly
evidenced in formulation A, where cells were cultured in chondrogenic medium and TGF-b1 was included
inside the hydrogel. Cartilage matrix-specific molecules were stained with Alcian blue and formulation A
revealed higher accumulation, compared to B (chondrogenic medium without TGF-b1) and C (presence of
TGF-b1 cultured in DMEM medium). Scale bar represents 60 mm.
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in constructs from formulation A, in which the GF is dispersed within the matrix.
Additionally, culture conditions and the presence of TGF-b1 also inﬂuenced the cell
viability and proliferation, revealing better results when the amount of TGF-b1 is higher,
i.e., when the GF was included in the gel and the constructs were cultured in chondrogenic
medium. TGF-b1 is responsible for initial cell–cell interactions and has the ability to
stimulate, grow, and diﬀerentiate the cells.23–25 After days 1 and 7, the formulation A,
with TGF-b1 inside the hydrogel, presented an enhanced viability and proliferation,
compared to other formulations. However, this diﬀerence was not observed after 14 days
of culture, which might be explained by the partial release of the GF from the structure,
according to the GF release proﬁle of k-carrageenan hydrogels observed in a previous
study.40 The eﬀect of the TGF-b1 became weaker with culture time, which might justify
the similarities of the results after 2-week period. Based on viability and proliferation results,
the GF inside the carrageenan cultured in basal media is less capable of sustaining
chondrogenic diﬀerentiation of hASCs compared to constructs cultured in a chondrogenic
medium. These suggest that higher GF concentration may be needed in such hydrogels to
induce a better cellular response for hASCs without using culture medium containing the GF
and other chondrogenic stimulators.
The histological and immunohistochemical analyses conﬁrmed the presence of cartilage-
speciﬁc matrix in the constructs. The Alcian staining was most intense in the pericellular
matrix, characteristics associated with cells found in native cartilage.19 When cultured in
chondrogenic medium and with TGF-b1 encapsulated into the hydrogel, higher expression
of collagen type II was obtained (Figure 6), conﬁrming the inﬂuence of the GF in
chondrogenic diﬀerentiation of hASCs, and that TGF-b1 was the ability to stimulate
production of proteoglycans and other components in the cartilage matrix.27,28
Figure 7. Immunolocalization of collagen type II in hASC–carrageenan constructs after 14 days of culture
(A, B, and C). Positive and negative controls were performed with human articular cartilage (D and E).
Higher formation of collagen type II was found in constructs incorporated with TGF-b1 and cultured in
chondrogenic medium (A). Scale bar represents 60 mm.
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The chondrogenesis of adult MSCs requires an environment containing strong chondrogenic
inducer, such as, TGF-b1, dexamethasone, or ascorbic acid.23–25,28 This is the reason why
constructs cultured in basal DMEM medium displayed signiﬁcantly lower expression of
cartilage-speciﬁc molecules. Constructs A and C were designed with a ﬁnal concentration
of GF similar to the typically applied for the chondrogenic diﬀerentiation of progenitor cells
(10 ng/mL).27 Thus, the inclusion of TGF-b1 in the hydrogel is not enough to induce
chondrogenic diﬀerentiation by itself but strongly enhances it when acting synergistically
with chondrogenic medium.
The cell morphology inside the hydrogel was also aﬀected by changes in culture
environment (Figure 6). The majority of the cells had a spherical morphology, necessary
for the expression of chondrocytic phenotype which is related to the synthesis of ECM
components of cartilage.48 Similar cell morphology was observed previously in 3-D
carrageenan-based cultures of chondrocytes.49 These ﬁndings conﬁrm that carrageenan-
based hydrogels are suitable for cell encapsulation19 and k-carrageenan hydrogel networks
may mimic extracellular cartilage matrix.50 Additionally, due to the gelling properties of the
biomaterial and the transition temperature of the material close to the physiological one,
carrageenan-based hydrogels might be used in the future as an injectable system for TE,
envying a minimally invasive approach.
Conclusions
k-Carrageenan can be a suitable material for cartilage TE as it is noncytotoxic and an
eﬃcient cell entrapment. The simultaneous entrapment of TGF-b1 and hASCs inside the
hydrogel network enhanced the in-cell viability and proliferation during the ﬁrst week of
culture as well as, an increase in the expression of chondrogenic diﬀerentiation markers when
cultured in chondrogenic medium. It is possible to observe the initial steps of chondrogenic
diﬀerentiation of hASCs after just 14 days, showing that this cell source could be an
adequate option for cartilage TE.
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